What does diagnostics — non-amortizing intangible assets mean?

The value of intangible assets like brand names that do not lose value over a fixed period.

How do you interpret diagnostics — non-amortizing intangible assets?

Stable or increasing values suggest strong brand equity, while sudden decreases indicate potential impairment charges due to loss of market value.

How does diagnostics — non-amortizing intangible assets compare across companies?

Standard across healthcare and diagnostic firms holding significant intellectual property and acquired brand portfolios.

Revvity RVTY Diagnostics — Non-amortizing intangible assets

Discontinued — last reported Q4 '21

Similar metrics at other companies

LHDiagnostics — Goodwill

$5.61B—

ADiagnostics and Genomics — Indefinite-lived Intangible Assets, Purchase Accounting Adjustments

-$2.75M—

DHRDiagnostics — Identifiable assets

$14.66B—

RALSensors and Safety Systems — Indefinite-lived intangibles

$17.5M—

TEC

TECHDiagnostics And Genomics — Finitelived Intangible Assets Acquired1

$0—

TEC

TECHDiagnostics And Spatial Biology — Goodwill

$553.62M+1.1%

Other financials

Income statement

See full

Revenue$711.1M+7.0%

Gross profit$387.7M+3.2%

Operating income$75.9M+5.1%

Net income$40.7M-3.6%

EPS (diluted)$0.36+2.9%

Balance sheet

See full

Cash & equivalents$861.5M-24.3%

Total debt$3.9B+17.8%

Total equity$7.2B-5.9%

Total assets$12.0B-2.9%

Cash flow

See full

Operating cash flow$115.2M-10.1%

CapEx$19.8M+23.7%

Free cash flow$95.5M-14.9%

Valuation

See full

Market cap$11.16B-22.9%

Enterprise value$14.24B-13.7%

P/E46.5×-4.0×

P/S3.8×-1.4×

Profitability

See full

Gross margin48.5%—

Operating margin12.4%-1.1pp

Net margin8.3%-2.1pp

FCF margin17%-1.9pp

Returns & leverage

See full

Return on equity3.2%-0.5pp

Debt / equity0.5×+0.1×

Current ratio1.7×-1.9×

Where this comes from

Reported directly by Revvity in its filing.

Tagged under the XBRL concept us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill.

The official record: Revvity’s 10-K, filed March 3, 2022, on SEC EDGAR. View the filing →

Ask your AI about Revvity's diagnostics — non-amortizing intangible assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Revvity's diagnostics — non-amortizing intangible assets?: Revvity (RVTY) reported diagnostics — non-amortizing intangible assets of $0 in Q4 2021.
What does diagnostics — non-amortizing intangible assets mean?: The value of intangible assets like brand names that do not lose value over a fixed period.
How do you interpret diagnostics — non-amortizing intangible assets?: Stable or increasing values suggest strong brand equity, while sudden decreases indicate potential impairment charges due to loss of market value.
How does diagnostics — non-amortizing intangible assets compare across companies?: Standard across healthcare and diagnostic firms holding significant intellectual property and acquired brand portfolios.